Company · Ownership research

Neumora Therapeutics, Inc. NMRA

CIK 0001885522

Form 3 statements with an event date from Sep 1, 2023 to Sep 24, 2026.

Insider trading Initial holdings Institutional holders

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Where insider ownership starts.

Form 3 is an initial ownership statement filed when someone becomes a reporting insider. These holdings do not mean they bought shares that day.

2023, from Sep 1, 202317 of 17 statements

Holdings date	Insider	Initial holdings
2023-12-11	Duncan Jason Chief Legal Officer	No securities reported	▾
2023-09-14	Milligan Michael Lee See Remarks	3.82K shares · 3 derivative holdings	▾
2023-09-14	FMR LLC 10% owner · See Remark 1	1.91M shares · 4 derivative holdings	▾
2023-09-14	CRANDELL KEITH · NELSEN ROBERT · BYBEE CLINTON · GILLIS STEVEN · ARCH Venture Partners X, LLC · ARCH Venture Fund XII, L.P. · ARCH Venture Partners XII, LLC · ARCH Venture Partners XII, L.P. 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner	2 stock holdings · 5 derivative holdings	▾
2023-09-14	ARCH Venture Fund VII, L.P. · ARCH Venture Partners VII, LLC · ARCH Venture Partners VII, L.P. · ARCH Venture Partners VIII, LLC · ARCH Venture Fund VIII Overage, L.P. · ARCH Venture Fund X, L.P. · ARCH Venture Fund X Overage, L.P. · ARCH Venture Partners X Overage, L.P. · ARCH Venture Partners X, LLC · ARCH Venture Partners X, L.P. 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner	2 stock holdings · 5 derivative holdings	▾
2023-09-14	Burow Kristina Director · 10% owner	2 stock holdings · 6 derivative holdings	▾
2023-09-14	Halawa Alaa Director	No securities reported	▾
2023-09-14	Aurora Daljit Singh Chief Strategy Officer	114.70K shares · 3 derivative holdings	▾
2023-09-14	Lenz Robert A. Head of R&D	No securities reported	▾
2023-09-14	Piacquad David Director	No securities reported	▾
2023-09-14	Ho Maykin Director	1 derivative holding	▾
2023-09-14	Suh Carol Y. Chief Operating Officer	289.67K shares · 4 derivative holdings	▾
2023-09-14	BERNS PAUL L Director	7.65M shares · 3 derivative holdings	▾
2023-09-14	AMGEN INC 10% owner	2 derivative holdings	▾
2023-09-14	Gosebruch Henry O President & CEO · Director	2 stock holdings · 1 derivative holding	▾
2023-09-14	Fust Matthew K Director	3 derivative holdings	▾
2023-09-14	Pinto Joshua Chief Financial Officer	238.97K shares · 5 derivative holdings	▾

Showing 17 / 17 statements in 2023. The complete set is available through the API.

Neumora Therapeutics, Inc. · NMRA

Follow the people behind the trades.

Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For 2023, this page lists 17 of 17 statements.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

list_initial_holdings
{"ticker":"NMRA","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.